Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimmune Imaging in PTSD with PET
NCT04236986Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2017
- Primary completion
- May 2023
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of lipopolysaccharide endotoxin (2 arms), sponsored by Yale University. Primary endpoints: Baseline TSPO Availability and Post-LPS TSPO Availability. Started Mar 2017; status: completed.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT04236986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236986.